Zhou Chengzhi
Clinical trials sponsored by Zhou Chengzhi, explained in plain language.
-
New PET scan could predict who benefits from targeted lung cancer therapy
Disease control Not yet recruitingThis study investigates a drug called sacituzumab govitecan, which targets the TROP2 protein, in people with advanced non-small cell lung cancer that has stopped responding to standard EGFR-targeted treatments. Researchers are also comparing two types of PET/CT scans—one standard…
Phase: PHASE2 • Sponsor: Zhou Chengzhi • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can stem cell mist heal lungs damaged by cancer immunotherapy?
Disease control Not yet recruitingThis early-phase trial tests whether inhaling tiny particles from stem cells (exosomes) can help heal lung inflammation caused by immunotherapy drugs. The study involves 40 adults with cancer who have persistent lung problems despite standard steroid treatment. Participants will …
Phase: PHASE1, PHASE2 • Sponsor: Zhou Chengzhi • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC